or
forgot password
  • cancer clinical trials in norwich, CT

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
    GSK Clinical Trials Call Center
    Norwich, Connecticut 06360
    Colorectal Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Norwich, Connecticut 06360
    Non-Hodgkin's Lymphoma
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Colorectal Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    William W. Backus Hospital

    Trial Locations
    William W. Backus Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Prostate Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Prostate Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Eastern Connecticut Hematology & Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer, Fatigue, Sleep Disorders
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Eastern Connecticut Hematology Oncology
    Norwich, Connecticut 06360
    Breast Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    William W. Backus Hospital

    Trial Locations
    William W. Backus Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Endometrial Cancer, Fatigue, Neurotoxicity
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Brain and Central Nervous System Tumors, Neurotoxicity
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    William Backus Hospital
    Norwich, Connecticut 06360
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Advanced Prostate Cancer, Prostatic Neoplasms
    Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
    Eastern CT Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Prostate Cancer
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    William Backus Hospital
    Norwich, Connecticut 06360
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001
    Eastern CT Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Prostate Cancer
    Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
    Norwich Cancer Center
    Norwich, Connecticut 06360
    Breast Cancer
    Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Norwich Cancer Center
    Norwich, Connecticut 06360
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    William W. Backus Hospital
    Norwich, Connecticut 06360
    Colorectal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Breast Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Prostate Cancer
    Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Colorectal Cancer
    Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Pancreatic Cancer
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    Eastern Connecticut Oncology
    Norwich, Connecticut 06360-2910
    Pancreatic Cancer
    Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
    GSK Clinical Trials Call Center
    Norwich, Connecticut 06360
    Small Cell Lung Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Lung Cancer
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Eastern Connecticut Hematology & Oncology
    Norwich, Connecticut 06360
    Non-small Cell Lung Cancer